Triple-negative breast cancer (TNBC) poses a significant challenge in terms of prognosis
and disease recurrence. The limited treatment options and the development of resistance to …

Breast cancer (BC) remains an enigmatic fatal modality ubiquitously prevalent in different
parts of the world. Contemporary medicines face severe challenges in remediating and …

Triple-negative breast cancer (TNBC) is the most aggressive subtype of breast cancer, with
clinical features of high metastatic potential, susceptibility to relapse, and poor prognosis …

Simple Summary Triple-negative breast cancer (TNBC) is the most aggressive breast cancer
subtype accounting for approximately 10–20% of all cases. Due to a lack of actionable …

Breast cancer comprises about 30% of all new female cancers each year and is the most
common malignant cancer in women in the United States. Breast cancer cell lines have …

Triple-negative breast cancer (TNBC) is usually the most malignant and aggressive
mammary epithelial tumor characterized by the lack of expression for estrogen receptors …

Breast cancer (BC) is one of the main causes of cancer-related death worldwide. The
heterogenicity of breast tumors and the presence of tumor resistance, metastasis, and …

Triple-negative breast cancer (TNBC) is one of the most aggressive types of cancer. Despite
decades of intense investigation, treatment options remain limited, and rapid recurrence with …

The second leading cause of cancer death in women worldwide is breast cancer (BC), and
despite significant advances in BC therapies, a significant proportion of patients develop …

Cancer is a major public health concern worldwide; it is the second-highest cause of death
in the United States. According to projections of cancer incidence and mortality rates …